Basic science: (OCTOBER 2007)

Abstract

1. Cao YX, Luo JL and Karin M. IkB kinase a kinase activity is required for self-renewal of ErbB2/Her2-transformed mammary tumorinitiating cells. Proc Natl Acad Sci USA 2007; 104: 15852–15857. 2. Charafe-Jauffret E, Monville F, Bertucci F, Esterni B, Ginestier C, Finetti P, Cervera N, Geneix J, Hassanein M, Rabayrol L, Sobol H, Taranger-Charpin C, Xerri L, Viens P, Birnbaum D and Jacquemier J. Moesin expression is a marker of basal breast carcinomas. Int J Cancer 2007; 121: 1779–1785. 3. Cheng JW, Yu DV, Zhou JH and Shapiro DJ. Tamoxifen induction of CCAAT enhancerbinding protein a is required for tamoxifeninduced apoptosis. J Biol Chem 2007; 282: 30535–30543. 4. Degen M, Brellier F, Kain R, Ruiz C, Terracciano L, Orend G and Chiquet-Ehrismann R. Tenascin-W is a novel marker for activated tumor stroma in low-grade human breast cancer and influences cell behavior. Cancer Res 2007; 67: 9169–9179. 5. Durocher F, Labrie Y, Ouellette G and Simard J. Genetic sequence variations and ADPRT haplotype analysis in French Canadian families with high risk of breast cancer. J Hum Genet 2007; 52: 963–977. 6. Emlet DR, Brown KA, Kociban DL, Pollice AA, Smith CA, Ong BBL and Shackney SE. Response to trastuzumab, erlotinib, and bevacizumab, alone and in combination, is correlated with the level of human epidermal growth factor receptor-2 expression in human breast cancer cell lines. Mol Cancer Ther 2007; 6: 2664–2674. 7. Jakobsen CG, Rasmussen N, Laenkholm AV and Ditzel HJ. Phage display-derived human monoclonal antibodies isolated by binding to the surface of live primary breast cancer cells recognize GRP78. Cancer Res 2007; 67: 9507–9517. 8. John EM, Schwartz GG, Koo J, Wang W and Ingles SA. Sun Exposure, Vitamin D Receptor Gene Polymorphisms, and Breast Cancer Risk in a Multiethnic Population. Am J Epidemiol 2007; 166: 1409–1419. 9. Karnoub AE, Dash AB, Vo AP, Sullivan A, Brooks MW, Bell GW, Richardson AL, Polyak K, Tubo R and Weinberg RA. Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature 2007; 449: 557–563. 10. Khaleque MA, Bharti A, Gong J, Gray PJ, Sachdev V, Ciocca DR, Stati A, Fanelli M and Calderwood SK. Heat shock factor 1 represses estrogen-dependent transcription through association with MTA1. Oncogene 2007; 10.1038/sj.onc.1210834. 11. Kim SJ, Nakayama S, Miyoshi Y, Taguchi T, Tamaki Y, Matsushima T, Torikoshi Y, Tanaka S, Yoshida T, Ishihara H and Noguchi S. Determination of the specific activity of CDK1 and CDK2 as a novel prognostic indicator for early breast cancer. Ann Oncol 2007; 10.1093/ annonc/mdm358. 12. Kotzsch M, Sieuwerts A, Grosser M, Meye A, Fuessel S, Meijer-van Gelder M, Smid M, Schmitt M, Baretton G, Luther T, Magdolen V and Foekens J. Urokinase receptor splice variant uPAR-del4/5-associated gene expression in breast cancer: identification of rab31 as an independent prognostic factor. Breast Cancer Res Treat 2007; 10.1007/s10549-0079782-6. 13. Lauber SN and Gooderharn NJ. The cooked meat-derived genotoxic carcinogen 2-Amino3-Methylimidazo[4,5-b]Pyridine has potent hormone-like activity: Mechanistic support for a role in breast cancer. Cancer Res 2007; 67: 9597–9602. 14. Li CI, Malone KE, Daling JR, Potter JD, Bernstein L, Marchbanks PA, Strom BL, Simon MS, Press MF, Ursin G, Burkman RT, Folger SG, Norman S, McDonald JA and Spirtas R. Timing of Menarche and First Full-Term Birth in Relation to Breast Cancer Risk. Am J Epidemiol 2007; 10.1093/aje/kwm271. 15. Lu DM, Sivaprasad U, Huang J, Shankar E, Morrow S and Basu A. Protein kinase C-epsilon BCO/665/2007/JW